Progesterone and the cycle: why does it fall first in perimenopause?

Summary

Perimenopause is usually described as "estrogen falling"; in fact one of the earliest changes is in progesterone. Progesterone is produced only after ovulation; as ovulation becomes less frequent or weaker, progesterone falls, while estrogen is still high and erratic. This imbalance creates the typical picture of perimenopause: cycles that shorten and then lengthen, heavier bleeding, breast tenderness, bloating, disturbed sleep and rising anxiety. That is why some doctors assess the progesterone side first in perimenopause. Recording your own cycle is the only way to make this pattern visible.

What is happening?

In a regular cycle, the follicular tissue left after ovulation (the corpus luteum) produces progesterone for about two weeks. Progesterone stabilizes the lining of the womb, raises body temperature slightly, has a calming effect in the brain and balances the effects of estrogen.

As ovarian reserve declines in perimenopause:

• Ovulation is skipped (an anovulatory cycle): No progesterone is produced at all; estrogen is left unopposed, the lining of the womb thickens excessively and eventually there is irregular, often heavy bleeding.

• Ovulation happens but is weak (luteal insufficiency): Progesterone is produced in small amounts and for a short time; the cycle shortens and premenstrual symptoms intensify.

• Meanwhile estrogen does not fall — it fluctuates: Follicles stimulated by rising FSH produce occasional high estrogen peaks. High estrogen that progesterone is not balancing causes breast tenderness, bloating and fluid retention. Headache attacks can also become more frequent in this period; what triggers migraine is the sudden drops in estrogen, and fluctuation makes those drops more frequent.

So in early perimenopause the common picture is not "estrogen deficiency" but "progesterone deficiency with estrogen excess". In late perimenopause, as the follicles run out, estrogen falls too and hot flashes come to the fore.

What do we know?

• Progesterone falls early: Studies of the endocrinology of the menopause transition have shown that the rate of ovulation drops and progesterone production declines even while cycles are still regular ¹; large cohorts (SWAN) also confirm that luteal progesterone falls and estrogen fluctuates in perimenopause. The "progesterone first" order may not be the same in every woman; the STRAW+10 staging is based not on the order of hormones but on the variability in cycle length — and that variability is the outward expression of irregular ovulation ⁶.

• Progesterone has effects of its own, but they are limited: In a randomized, placebo-controlled trial in postmenopausal women, oral micronized progesterone on its own significantly reduced hot flashes and night sweats compared with placebo ³. In a more recent and larger trial in perimenopausal women, the hot flash score showed no significant difference from placebo, but the perception of night sweats and sleep quality improved ⁷. In other words, in perimenopause progesterone's main proven contribution is to sleep and night-time symptoms; on its own it may not be enough for hot flashes. Its beneficial effect on sleep and its anxiety-reducing properties are among the reasons guidelines describe micronized progesterone as "possibly preferable" in women who have a womb ⁵.

• Cyclical use fits perimenopause: In perimenopause a progestogen is usually taken during a defined part of the month (cyclically); this accompanies the natural cycle that is still running and sheds the lining of the womb regularly. A continuous regimen is preferred at least a year after the last period ⁵. Which regimen is right for you is determined by your doctor.

• Over-the-counter "progesterone creams" do not work: A randomized trial showed that low-dose progesterone creams applied to the skin do not achieve meaningful levels in the blood and do not protect the lining of the womb; these products cannot be used as womb protection alongside estrogen ⁴.

• Bone and progesterone: It has been suggested that progesterone may have a role in bone formation that is independent of estrogen; the evidence is still limited and guidelines do not recommend progesterone on its own for bone ².

What does this give you?

• Record your cycle: The start of your period, its length, how heavy it is, and any spotting. The cycle calendar in Lumia keeps this on the same time axis as your symptoms; patterns such as "my sleep breaks down in the week before heavy bleeding" become visible this way.

• Read your symptoms "against the cycle": Breast tenderness, bloating and anxiety concentrating in the second half of the cycle is the typical trace of a progesterone-estrogen imbalance. Being able to describe this to your doctor with dates is valuable.

• Enter your regimen correctly: If your doctor has prescribed cyclical progesterone, enter it in Lumia with the "by cycle" option and the day range your doctor gave you; the calendar will show and remind you of those days. Lumia does not recommend a day range or a dose.

• Be wary of "natural progesterone cream" advertising: Prescription micronized progesterone and cosmetic creams are not the same thing.

Sources

1. Prior JC. Perimenopause: the complex endocrinology of the menopausal transition. Endocr Rev. 1998;19(4):397-428.
2. Prior JC. Progesterone for the prevention and treatment of osteoporosis in women. Climacteric. 2018;21(4):366-374.
3. Hitchcock CL, Prior JC. Oral micronized progesterone for vasomotor symptoms: a placebo-controlled randomized trial. Menopause. 2012;19(8):886-893.
4. Wren BG, et al. Transdermal progesterone and its effect on vasomotor symptoms, blood lipid levels, bone metabolic markers, moods, and quality of life. Menopause. 2003;10(1):13-18.
5. The Menopause Society. The 2022 Hormone Therapy Position Statement. Menopause. 2022;29(7):767-794.
6. Harlow SD, et al. Executive summary of the Stages of Reproductive Aging Workshop + 10. Menopause. 2012;19(4):387-395.
7. Prior JC, et al. Oral micronized progesterone for perimenopausal night sweats and hot flushes: a Phase III Canada-wide randomized placebo-controlled 4 month trial. Sci Rep. 2023;13:9082.

Related articles

• How do hormones change during this period? 5 min read
• Irregular cycles: when should you worry? 5 min read
• What are the types and forms of HRT? 6 min read
• Why does sleep break down? 5 min read